Container and method for storing a pharmaceutical agent
US-9068565-B2 · Jun 30, 2015 · US
US10201660B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10201660-B2 |
| Application number | US-201314647189-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2013 |
| Priority date | Nov 30, 2012 |
| Publication date | Feb 12, 2019 |
| Grant date | Feb 12, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method and apparatus for plasma modifying a workpiece such as a medical barrel, medical barrel, vial, or blood tube is described. Plasma is provided within the lumen of the workpiece. The plasma is provided under conditions effective for plasma modification of a surface of the workpiece. A magnetic field is provided in at least a portion of the lumen. The magnetic field has an orientation and field strength effective to improve the uniformity of plasma modification of the generally cylindrical interior surface 16 of the generally cylindrical interior surface 16.
Opening claim text (preview).
The invention claimed is: 1. A medical syringe barrel or medical cartridge barrel comprising: a wall having a generally cylindrical interior surface defining at least a portion of a lumen, the generally cylindrical interior surface having an inside diameter of 4 to 15 mm and the aspect ratio between the length and inside diameter of the generally cylindrical interior surface subjected to PECVD is from 2 to 10; and a PECVD set of one or more plasma enhanced chemical vapor deposition coatings or layers on at least a portion of the generally cylindrical interior surface, the PECVD set comprising: a barrier coating or layer having a mean thickness from 10 to 500 nm with a standard deviation less than the mean thickness; and a pH protective coating or layer between the barrier coating or layer and the lumen, in which a Fourier transform infrared spectroscopy (FTIR) absorbance spectrum of the pH protective coating or layer has a ratio greater than 0.75 and at most 1.7 between: the maximum amplitude of the Si—O—Si symmetrical stretch peak between about 1000 and 1040 cm −1 , and the maximum amplitude of the Si—O—Si asymmetric stretch peak between about 1060 and about 1100 cm −1 . 2. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the medical syringe barrel or medical cartridge barrel has an attached hypodermic needle, the generally cylindrical surface having a needle end, a back end, and a body portion between the ends. 3. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the standard deviation is at least 20% of the mean thickness. 4. The medical syringe barrel or medical cartridge barrel of claim 1 , made of COC (cyclic olefin copolymer), COP (cyclic olefin polymer), PET (polyethylene terephthalate), polypropylene, polycarbonate, polystyrene, polymethylmethacrylate, glass, or a combination of two or more of these. 5. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the barrier coating or layer consists essentially of SiO x , in which x is from 1.5 to 2.9 as determined by X-ray photoelectron spectroscopy (XPS). 6. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the oxygen barrier improvement factor of the wall and PECVD set, compared to the wall without the PECVD set, is from 5 to 12. 7. The medical syringe barrel or medical cartridge barrel of claim 1 , further comprising a closure seated to the medical barrel to form a closed lumen, in which the lumen has a volume between 0.5 and 50 ml and the inward oxygen transmission rate through the wall and the PECVD set is from 0.0012 to 0.00048 cubic cm per package per day, at 20° C., at atmospheric pressure outside the wall. 8. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the PECVD set is effective to maintain an oxygen barrier improvement factor, versus a barrel without the PECVD set, of at least 5 and at most 31 after the PECVD set is stored in contact with U.S. Pharmacopeia Water for Injection having a pH of 7.0 for a period of three months at a temperature of 25° C. 9. The medical syringe barrel or medical cartridge barrel of claim 1 , further comprising a fluid composition in the lumen having a pH between 4 and 9 and a closure retaining the fluid composition in the lumen, defining a fluid storage package. 10. The medical syringe barrel or medical cartridge barrel of claim 1 , wherein the medical syringe barrel or medical cartridge barrel is made of transparent material. 11. The medical syringe barrel or medical cartridge barrel of claim 1 , wherein the medical syringe barrel or medical cartridge barrel is made of injection moldable thermoplastic material. 12. The medical syringe barrel or medical cartridge barrel of claim 1 , wherein the medical syringe barrel or medical cartridge barrel is made of COC (cyclic olefin copolymer), COP (cyclic olefin polymer), PET (polyethylene terephthalate), polypropylene, polycarbonate, polystyrene, polymethylmethacrylate, glass, or a combination of two or more of these. 13. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the pH protective coating or layer consists essentially of SiO x C y , in which x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3, each as measured by XPS. 14. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the pH protective coating or layer consists essentially of the following atomic ratios of silicon, oxygen, and carbon as determined by X-ray photoelectron spectroscopy, and atomic ratio of hydrogen as determined by Rutherford backscattering spectrometry: ATOMIC RATIOS Si O C H 1 0.5 to 2.4 0.6 to 3 2 to 9. 15. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the pH protective coating or layer has a mean thickness from 50 to 500 nm. 16. The medical syringe barrel or medical cartridge barrel of claim 1 , further comprising a tie coating or layer consisting essentially of SiO x C y , in which x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3, each as measured by XPS. 17. The medical syringe barrel or medical cartridge barrel of claim 16 , in which the tie coating or layer consists essentially of the following atomic ratios of silicon, oxygen, and carbon as determined by X-ray photoelectron spectroscopy, and atomic ratio of hydrogen as determined by Rutherford backscattering spectrometry: ATOMIC RATIOS Si O C H 1 0.5 to 2.4 0.6 to 3 2 to 9. 18. The medical syringe barrel or medical cartridge barrel of claim 1 , in which the PECVD set is effective to maintain an oxygen barrier improvement factor, versus a barrel without the PECVD set, of at most 31 after the PECVD set is stored in contact with U.S. Pharmacopeia Water for Injection having a pH of 7.0 for a period of three months at a temperature of 25° C. 19. The medical syringe barrel or medical cartridge barrel of cla
containing silicon · CPC title
using radio frequency discharges · CPC title
specially adapted for improving sealing or sliding · CPC title
the material being a coating or protective layer · CPC title
Materials for reducing friction · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.